Semilepidinoside B

Metabolite details

Identifier

ASPNXCICLVYQCJ-UVLCOCDESA-N

InChI Key

ASPNXCICLVYQCJ-UVLCOCDESA-N

IUPAC name

(2R,3R,4S,5R,6S)-2-(hydroxymethyl)-6-[4-(1H-imidazol-2-ylmethyl)-2-methoxyphenoxy]oxane-3,4,5-triol

Preferred name

Semilepidinoside B

INN name

—

Synonym

—

ChEBI

CHEBI:175697

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
• Metabolic Responses of a Model Green Microalga Euglena gracilis to Different Environmental Stresses
• Mechanical force promotes dimethylarginine dimethylaminohydrolase 1-mediated hydrolysis of the metabolite asymmetric dimethylarginine to enhance bone formation
• Metabolism Disorder Promotes Isoproterenol-induced Myocardial Injury in Mice with High Temperature and High Humidity and High-Fat Diet
• DT-109 ameliorates nonalcoholic steatohepatitis in nonhuman primates
• Transcriptomic dynamics control rapid transition of core crop functions in 'lactating' pigeon
• Alterations in the gut microbiota and metabolomics of seafarers after a six-month sea voyage

Observed in differential profiles

• Control_vs_nsPEF_7_day
• Control_vs_Paramycin
• Control_vs_Exercise
• Control_vs_Isoproterenol
• Control_Liver_vs_Treatment_Liver
• Male_19_days_vs_Male_1_day
• Control_0d_vs_Treatment_180d